Search: WFRF:(Åkerman Linda)
> (2010-2014) >
Long-Lasting Immune...
Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
-
- Axelsson, Stina (author)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
- Chéramy, Mikael (author)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
- Hjorth, Maria (author)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
show more...
-
- Pihl, Mikael (author)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
- Åkerman, Linda (author)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
- Martinuzzi, Emanuela (author)
- St Vincent de Paul Hospital
-
- Mallone, Roberto (author)
- St Vincent de Paul Hospital
-
- Ludvigsson, Johnny (author)
- Östergötlands Läns Landsting,Linköpings universitet,Pediatrik,Hälsouniversitetet,Barn- och ungdomskliniken i Linköping
-
- Casas, Rosaura (author)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
show less...
-
(creator_code:org_t)
- 2011-12-12
- 2011
- English.
-
In: PLOS ONE. - : Public Library of Science. - 1932-6203. ; 6:12
- Related links:
-
https://liu.diva-por... (primary) (Raw object)
-
show more...
-
https://journals.plo...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- A phase II clinical trial with glutamic acid decarboxylase (GAD) 65 formulated with aluminium hydroxide (GAD-alum) has shown efficacy in preserving residual insulin secretion in children and adolescents with recent-onset type 1 diabetes (T1D). We have performed a 4-year follow-up study of 59 of the original 70 patients to investigate long-term cellular and humoral immune responses after GAD-alum-treatment. Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with GAD(65). Frequencies of naive, central and effector memory CD4+ and CD8+ T cells were measured, together with cytokine secretion, proliferation, gene expression and serum GAD(65) autoantibody (GADA) levels. We here show that GAD-alum-treated patients display increased memory T-cell frequencies and prompt T-cell activation upon in vitro stimulation with GAD(65), but not with control antigens, compared with placebo subjects. GAD(65)-induced T-cell activation was accompanied by secretion of T helper (Th) 1, Th2 and T regulatory cytokines and by induction of T-cell inhibitory pathways. Moreover, post-treatment serum GADA titres remained persistently increased in the GAD-alum arm, but did not inhibit GAD(65) enzymatic activity. In conclusion, memory T- and B-cell responses persist 4 years after GAD-alum-treatment. In parallel to a GAD(65)-induced T-cell activation, our results show induction of T-cell inhibitory pathways important for regulating the GAD(65) immunity.
Keyword
- MEDICINE
- MEDICIN
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
-
PLOS ONE
(Search for host publication in LIBRIS)
To the university's database